DOI: 10.1148/radiol.240427 ISSN: 0033-8419
Automated CT Measurement of Total Kidney Volume for Predicting Renal Function Decline after 177Lu Prostate-specific Membrane Antigen–I&T Radioligand Therapy
Lisa Steinhelfer, Friederike Jungmann, Manuel Nickel, Georgios Kaissis, Marie-Luise Hofer, Robert Tauber, Christoph Schmaderer, Isabel Rauscher, Bernhard Haller, Marcus R. Makowski, Matthias Eiber, Rickmer F. BrarenA decrease in total kidney volume after lutetium 177 prostate-specific membrane antigen radioligand therapy predicted renal function decline at 12 months in patients with metastatic castration-resistant prostate cancer.